Precision Medicine Research

This blog serves as an introduction to a Nature paper that addresses single-cell RNA sequencing and how it can be used as a robust tool for identifying predictive biomarkers across multiple sites.

The human body is formed of a large diversity of cells and cell types, each with unique expression patterns and molecular complexities.

A group of scientists at the Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM) have developed a new microscopy technique for blood cells that saves time, money, and, most importantly, is already helping to uncover new immunotherapy treatments for cancer.

Decades of research and technological advancements are enabling scientists to more fully understand how tumors proliferate, metastasize, and evolve.

Precision medicine is an approach that considers patients’ individual differences in genes, environment, and lifestyle to personalize medical treatments.

Increasingly, we are realizing that every tumor is different, meaning that a one-size-fits-all approach to cancer treatment will be ineffective.

Advances in genomic sequencing and the massive expansion in treatment options over the past two decades are changing our approach to cancer treatment. Whereas older therapeutic strategies relied on non-cancer-specific mechanisms of action, molecular profiling has supported the rise of targeted therapies